Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.714 SEK | +0.23% | +0.23% | -62.29% |
08/05 | Kancera AB Announces Executive Changes | CI |
03/05 | Kancera AB Reports Positive Results from the Clinical Phase I Study with KAND145 in Healthy Subjects | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.95Cr | - | - | - | |||
12TCr | ||||||
11TCr | ||||||
2.34TCr | - | |||||
2.18TCr | - | |||||
1.81TCr |
- Stock Market
- Equities
- KAN Stock
- Charts Kancera AB
- Sector Chart